Quality Improvement in Health Care (한국의료질향상학회지)

Korean Society for Quality in Health Care (한국의료질향상학회)
권호 표지
DOI QR코드

DOI QR Code

Regional Differences in Access to Clinical Trials for Cancer in Korea

  • Kim, Woorim (Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center) ;
  • Jang, Seongkyeong (Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center) ;
  • Chang, Yoon Jung (Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center)
  • Received : 2021.03.11
  • Accepted : 2021.04.19
  • Published : 2021.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The ability to access clinical trials for cancer treatment is important. This study investigated whether regional differences exist in oncologic clinical trial protocols conducted in South Korea. Methods: Records of all approved oncologic clinical trials conducted in 2019 were downloaded from the Republic of Korea Ministry of Food and Drug Safety. The study covered Seoul, the capital area, other metropolitan cities, and provincial areas. Descriptive statistics summarized the distribution patterns of clinical trials by region. Results: A total of 202 oncologic clinical trials were conducted in 63 institutions in 2019. Of these protocols, 186 (92%) were available in Seoul, 120 (59%) in the capital area, 64 (32%) in metropolitan cities, and 66 (33%) in provincial areas. More regional differences in protocol availability were observed in domestic trials, investigator-initiated trials, phase 1 and 2 trials, and smaller-scale trials. Conclusion: Most oncologic clinical trials were conducted in medical institutions located in Seoul, with the rest conducted in the capital area, metropolitan cities, and provincial areas. The findings reveal clear differences in protocol availability between Seoul and the other regions. Measures designed to improve geographical access to oncologic clinical trials may be needed given their growing importance in cancer treatment.

Keywords

References

  1. Im SA, Lee DW, Kang R, Kim JH, Kim DW, Jang IJ, et al. Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea. Chinese Clinical Oncology.2019;8(3):27. https://doi.org/10.21037/cco.2019.06.05
  2. Shim BY, Park SH, Lee S, Kim JS, Lee KE, Kang YK, et al. Current status and challenges of cancer clinical trials in Korea. Cancer Research and Treatment. 2016;48(1):20-7. https://doi.org/10.4143/crt.2014.317
  3. Chee DH. Korean clinical trials: its current status, future prospects, and enabling environment. Translational and Clinical Pharmacology. 2019;27(4):115-8. https://doi.org/10.12793/tcp.2019.27.4.115
  4. Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. American Society of Clinical Oncology educational book. 2016;36(36):185-98. https://doi.org/10.1200/EDBK_156686
  5. Moon TJ. Light and shadows of the Korean healthcare system. Journal of Korean Medical Science. 2012;27(Suppl):S3-S6. https://doi.org/10.3346/jkms.2012.27.S.S3
  6. Frost & Sullivan. Asia: Preferred Destination for Clinical Trials 2020. Santa Clara, United States of America: Frost & Sullivan; 2020.
  7. Scoggins JF, Ramsey SD. A national cancer clinical trials system for the 21st century: reinvigorating the NCI cooperative group program. Journal of the National Cancer Institute. 2010;102(17):1371. https://doi.org/10.1093/jnci/djq291
  8. Lim Y, Lim JM, Jeong WJ, Lee KH, Keam B, Kim TY, et al. Korean cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate. Cancer Research and Treatment. 2017;49(4):1033-43. https://doi.org/10.4143/crt.2016.413
  9. Lee SJ, Park LC, Lee J, Kim S, Choi MK, Hong JY, et al. Unique perception of clinical trials by Korean cancer patients. BioMed Central Cancer. 2012;12(1):594.
  10. Jeong HS, Lee KS, Chee HK, Ahn HM, Sim SB. Thoracic and cardiovascular surgeons' perception of the concentration of cardiovascular operations in Seoul metropolitan area's hospitals. Korean Journal of Thoracic and Cardiovascular Surgery. 2016;49:53-9. https://doi.org/10.5090/kjtcs.2016.49.S1.S53